There’s a new plot twist in the takeover battle between French pharmaceutical giant Sanofi-Aventis and U.S. drugmaker Genzyme. A regulatory filing made by Genzyme on Thursday claims Sanofi may be willing to go much higher than …
After months of courting U.S. drugmaker Genzyme, French pharmaceutical company Sanofi-Aventis launched a hostile bid valued at approximately $18.5 billion, or $69 a share, for all outstanding shares of Genzyme common stock.
…
Avis Budget has increased its offer for Dollar Thrifty, firing the latest salvo in its bidding war for Dollar with archrival Hertz. It’s a familiar pattern in the world of mergers and acquisitions, and the data shows that inter…
Convenience-store chain 7-Eleven offered $2 billion to acquire competitor Casey’s General Stores, topping a hostile bid by Canada’s Alimentation Couche-Tard
Continue reading 7-Eleven Bids $2 Billion for Casey’s…